Wanbangde Pharmaceutical Holding Group Co Ltd Capital Reinvestment Ratio

Latest as of June 2025: 2.50x

Wanbangde Pharmaceutical Holding Group Co Ltd capital reinvestment ratio. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Capital Reinvestment Ratio of 2.50x as of June 2025, meaning it reinvests 2% of its operating cash flow (CN¥61.33 Million) in capital expenditures (CN¥153.03 Million). See Wanbangde Pharmaceutical Holding Group C free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.50x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥61.33 Million
CNY

Capital Expenditures

CN¥153.03 Million
CNY

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

Capital reinvestment ratio of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. This chart tracks Wanbangde Pharmaceutical Holding Group Co Ltd's Capital Reinvestment Ratio across 18 annual periods. See Wanbangde Pharmaceutical Holding Group C leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Wanbangde Pharmaceutical Holding Group Co Ltd Capital Reinvestment Ratio by Year (2003–2025)

Wanbangde Pharmaceutical Holding Group Co Ltd capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see 002082 operating cash flow.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.48x CN¥603.98 Million CN¥289.65 Million ▼ -34.8%
2024 0.74x CN¥120.22 Million CN¥88.43 Million ▼ -94.1%
2021 12.55x CN¥22.09 Million CN¥277.06 Million ▲ +238.7%
2020 3.70x CN¥151.01 Million CN¥559.24 Million ▲ +151.2%
2018 1.47x CN¥135.40 Million CN¥199.64 Million ▲ +4973.8%
2016 0.03x CN¥310.71 Million CN¥9.03 Million ▼ -98.4%
2015 1.82x CN¥16.76 Million CN¥30.47 Million ▲ +467.9%
2014 0.32x CN¥140.31 Million CN¥44.91 Million ▲ +502.5%
2013 0.05x CN¥234.35 Million CN¥12.45 Million ▼ -73.7%
2012 0.20x CN¥202.73 Million CN¥40.92 Million ▼ -25.6%
2010 0.27x CN¥162.26 Million CN¥44.02 Million ▼ -69.2%
2009 0.88x CN¥68.13 Million CN¥60.02 Million ▲ +51.7%
2008 0.58x CN¥253.06 Million CN¥146.92 Million ▼ -93.4%
2007 8.81x CN¥12.45 Million CN¥109.68 Million ▼ -67.0%
2006 26.70x CN¥3.50 Million CN¥93.47 Million ▲ +241.2%
2005 7.83x CN¥11.23 Million CN¥87.86 Million ▲ +160.2%
2004 3.01x CN¥32.69 Million CN¥98.30 Million ▲ +193.5%
2003 1.02x CN¥37.01 Million CN¥37.92 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow